Table 2. Trans-Isolate test results conducted on CSF samples collected from patients treated by MSF in Kebbi and Sokoto states, by location, February 16 to March 26, 2015.
*All 26 samples had PorA type P1.21-15,16. The 14 culture-positive isolates had genetic sequencing of ST-10217 PorA type P1.21-15,16 and FetA type F1-7. **PCR stands for Real-time polymerase chain reaction.
| Kebbi State | Sokoto State | Total | |
|---|---|---|---|
| All Trans-Isolate Tests (Culture and PCR**) | |||
| Total number of CSF samples tested | 18 | 13 | 31 |
| Total number of positive NmC samples (%) | 14 (78%) | 12 (92%) | 26* (84%) |
| Culture | |||
| Number of CSF samples tested | 8 | 6 | 14 |
| Number of positive NmC samples (%) | 8 (100%) | 6 (100%) | 14 (100%) |
| PCR | |||
| Number of CSF samples tested | 10 | 7 | 17 |
| Number of positive NmC samples (%) | 6 (60%) | 6 (86%) | 21 (71%) |